Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Weiming Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4943-8412; OpenAlex author ID A5101853910. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. MALAT1 promotes epithelial-mesenchymal transition of pancreatic cancer cells through the miR-141-5p-TGF-ß-TGFBR1/TGFBR2 axis. Co-author DOI 10.1684/ecn.2024.0495↗
  2. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. Co-author DOI 10.1080/21655979.2021.2016326↗
  3. Long Non-Coding RNA MIR4435-2HG Promotes Glycolysis and Tumor Immunity in Pancreatic Cancer Through Absorption of microRNA-582-5p to Target GPX8 Last author DOI 10.21203/rs.3.rs-1112369/v1↗
  4. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0071309↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huimin Lu · 2 shared papers, 2022–2024 · strength 0.41
  2. Zihe Wang · 2 shared papers, 2022–2024 · strength 0.41
  3. Zhenlu Li · 2 shared papers, 2021–2022 · strength 0.31
  4. Zhenlu Li · 1 shared paper, 2024 · strength 0.24
  5. Xing Huang · 1 shared paper, 2022 · strength 0.17
  6. DuJiang Yang · 1 shared paper, 2021 · strength 0.14
  7. Li Mao · 1 shared paper, 2021 · strength 0.14
  8. Huimin Lü · 1 shared paper, 2021 · strength 0.14
  9. Zhaoda Zhang · 1 shared paper, 2013 · strength 0.05
  10. Bole Tian · 1 shared paper, 2013 · strength 0.05
  11. Anping Su · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.